Ted Cohen

Associate Professor





National Institutes of Health, National Institute of General Medical Sciences
People: Laura White, Ted Cohen, William Hanage, Rene Niehus, Ben Cowling, Tyler Brown, Joseph Wu, Mauricio Santillana Guzman, Joseph Lewnard, Aimee Taylor, Ayesha Mahmud, Pablo Martinez de Salazar, Lerato Magosi, Edward Goldstein, Christine Tedijanto, Tigist Menkir, Sze Man Leung, Hsiao-Han Chang, Caroline Buckee, Pamela Martinez, Marc Lipsitch
2009 – 2020

Read More »


Gunasekera KS, Walters E, van der Zalm MM, Palmer M, Warren JL, Hesseling AC, Cohen T, Seddon JA. (2021). Development of a treatment-decision algorithm for HIV-uninfected children evaluated for pulmonary tuberculosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Walter KS, Colijn C, Cohen T, Mathema B, Liu Q, Bowers J, Engelthaler DM, Narechania A, Lemmer D, Croda J, Andrews JR. (2020). Genomic variant-identification methods may alter Mycobacterium tuberculosis transmission inferences. Microbial genomics

McQuaid CF, Cohen T, Dean AS, Houben RMGJ, Knight GM, Zignol M, White RG. (2020). adults. The European respiratory journal

Pitzer VE, Chitwood M, Havumaki J, Menzies NA, Perniciaro S, Warren JL, Weinberger DM, Cohen T. (2020). The impact of changes in diagnostic testing practices on estimates of COVID-19 transmission in the United States. medRxiv : the preprint server for health sciences

Cudahy PGT, Wilson D, Cohen T. (2020). Risk factors for recurrent tuberculosis after successful treatment in a high burden setting: a cohort study. BMC infectious diseases, 20(1)

Marx FM, Cohen T, Menzies NA, Salomon JA, Theron G, Yaesoubi R. (2020). Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis. The Lancet. Global health, 8(9)

Weinberger DM, Cohen T, Crawford FW, Mostashari F, Olson D, Pitzer VE, Reich NG, Russi M, Simonsen L, Watkins A, Viboud C. (2020). Estimating the early death toll of COVID-19 in the United States. bioRxiv : the preprint server for biology

Santos ADS, Oliveira RD, Lemos EF, Lima F, Cohen T, Cords O, Martinez L, Gonçalves C, Ko A, Andrews JR, Croda J. (2020). Yield, Efficiency and Costs of Mass Screening Algorithms for Tuberculosis in Brazilian Prisons. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Pitzer VE, Cohen T. (2020). Household studies provide key insights on the transmission of, and susceptibility to, SARS-CoV-2. The Lancet. Infectious diseases

Hsieh YL, Jahn A, Menzies NA, Yaesoubi R, Salomon JA, Girma B, Gunde L, Eaton JW, Auld A, Odo M, Kiyiika CN, Kalua T, Chiwandira B, Mpunga JU, Mbendra K, Corbett L, Hosseinipour MC, Cohen T, Kunkel A. (2020). Evaluation of 6-Month Versus Continuous Isoniazid Preventive Therapy for Mycobacterium tuberculosis in Adults Living With HIV/AIDS in Malawi. Journal of acquired immune deficiency syndromes (1999), 85(5)

Quaife M, Houben RMGJ, Allwood B, Cohen T, Coussens AK, Harries AD, van Kampen S, Marx FM, Sweeney S, Wallis RS, Menzies NA. (2020). Post-tuberculosis mortality and morbidity: valuing the hidden epidemic. The Lancet. Respiratory medicine

Hill AN, Cohen T, Salomon JA, Menzies NA. (2020). High-resolution estimates of tuberculosis incidence among non-U.S.-born persons residing in the United States, 2000-2016. Epidemics, (33)

Menzies NA, Bellerose M, Testa C, Swartwood N, Malyuta Y, Cohen T, Marks SM, Hill AN, Date AA, Maloney SA, Bowden SE, Grills AW, Salomon JA. (2020). Impact of Effective Global Tuberculosis Control on Health and Economic Outcomes in the United States. American journal of respiratory and critical care medicine

Leuba SI, Yaesoubi R, Antillon M, Cohen T, Zimmer C. (2020). Tracking and predicting U.S. influenza activity with a real-time surveillance network. PLoS computational biology, 16(11)

Gunasekera KS, Zelner J, Becerra MC, Contreras C, Franke MF, Lecca L, Murray MB, Warren JL, Cohen T. (2020). Children as sentinels of tuberculosis transmission: disease mapping of programmatic data. BMC medicine, 18(1)

Clarelli F, Palmer A, Singh B, Storflor M, Lauksund S, Cohen T, Abel S, Abel Zur Wiesch P. (2020). Drug-target binding quantitatively predicts optimal antibiotic dose levels in quinolones. PLoS computational biology, 16(8)

Yaesoubi R, Havumaki J, Chitwood M, Menzies NA, Gonsalves G, Salomon JA, Paltiel AD, Cohen T. (2020). Adaptive policies for use of physical distancing interventions during the COVID-19 pandemic. medRxiv : the preprint server for health sciences

Yaesoubi R, Cohen T, Hsu K, Gift TL, Chesson H, Salomon JA, Grad YH. (2020). Adaptive guidelines for the treatment of gonorrhea to increase the effective life span of antibiotics among men who have sex with men in the United States: A mathematical modeling study. PLoS medicine, 17(4)

MacPherson P, Khundi M, Nliwasa M, Choko AT, Phiri VK, Webb EL, Dodd PJ, Cohen T, Harris R, Corbett EL. (2019). Disparities in access to diagnosis and care in Blantyre, Malawi, identified through enhanced tuberculosis surveillance and spatial analysis. BMC medicine, 17(1)

Stimson J, Gardy J, Mathema B, Crudu V, Cohen T, Colijn C. (2019). Beyond the SNP Threshold: Identifying Outbreak Clusters Using Inferred Transmissions. Molecular biology and evolution, 36(3)

Arifin SMN, Zimmer C, Trotter C, Colombini A, Sidikou F, LaForce FM, Cohen T, Yaesoubi R. (2019). Cost-Effectiveness of Alternative Uses of Polyvalent Meningococcal Vaccines in Niger: An Agent-Based Transmission Modeling Study. Medical decision making : an international journal of the Society for Medical Decision Making, 39(5)

Marx FM, Yaesoubi R, Menzies NA, Salomon JA, Bilinski A, Beyers N, Cohen T. (2018). Tuberculosis control interventions targeted to previously treated people in a high-incidence setting: a modelling study. The Lancet. Global health, 6(4)

Yang C, Lu L, Warren JL, Wu J, Jiang Q, Zuo T, Gan M, Liu M, Liu Q, DeRiemer K, Hong J, Shen X, Colijn C, Guo X, Gao Q, Cohen T. (2018). Internal migration and transmission dynamics of tuberculosis in Shanghai, China: an epidemiological, spatial, genomic analysis. The Lancet. Infectious diseases, 18(7)

Cudahy PGT, Andrews JR, Bilinski A, Dowdy DW, Mathema B, Menzies NA, Salomon JA, Shrestha S, Cohen T. (2019). Spatially targeted screening to reduce tuberculosis transmission in high-incidence settings. The Lancet. Infectious diseases, 19(3)

Menzies NA, Cohen T, Hill AN, Yaesoubi R, Galer K, Wolf E, Marks SM, Salomon JA. (2018). Prospects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Model. American journal of epidemiology, 187(9)

Zimmer C, Leuba SI, Cohen T, Yaesoubi R. (2019). Accurate quantification of uncertainty in epidemic parameter estimates and predictions using stochastic compartmental models. Statistical methods in medical research, 28(12)

Menzies NA, Wolf E, Connors D, Bellerose M, Sbarra AN, Cohen T, Hill AN, Yaesoubi R, Galer K, White PJ, Abubakar I, Salomon JA. (2018). Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions. The Lancet. Infectious diseases, 18(8)

Zimmer C, Leuba SI, Yaesoubi R, Cohen T. (2018). Use of daily Internet search query data improves real-time projections of influenza epidemics. Journal of the Royal Society, Interface, 15(147)

Auld SC, Shah NS, Cohen T, Martinson NA, Gandhi NR. (2018). Where is tuberculosis transmission happening? Insights from the literature, new tools to study transmission and implications for the elimination of tuberculosis. Respirology (Carlton, Vic.)

Warren JL, Grandjean L, Moore DAJ, Lithgow A, Coronel J, Sheen P, Zelner JL, Andrews JR, Cohen T. (2018). Investigating spillover of multidrug-resistant tuberculosis from a prison: a spatial and molecular epidemiological analysis. BMC medicine, 16(1)

Thain N, Le C, Crossa A, Ahuja SD, Meissner JS, Mathema B, Kreiswirth B, Kurepina N, Cohen T, Chindelevitch L. (2019). Towards better prediction of Mycobacterium tuberculosis lineages from MIRU-VNTR data. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, (72)

Yaesoubi R, Trotter C, Colijn C, Yaesoubi M, Colombini A, Resch S, Kristiansen PA, LaForce FM, Cohen T. (2018). The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: A transmission dynamic modeling study. PLoS medicine, 15(1)

Morozova O, Cohen T, Crawford FW. (2018). Risk ratios for contagious outcomes. Journal of the Royal Society, Interface, 15(138)

Kunkel A, Furin J, Cohen T. (2017). Population implications of the use of bedaquiline in people with extensively drug-resistant tuberculosis: are fears of resistance justified?. The Lancet. Infectious diseases, 17(12)

Kunkel A, Lewnard JA, Pitzer VE, Cohen T. (2017). Antimicrobial Resistance Risks of Cholera Prophylaxis for United Nations Peacekeepers. Antimicrobial agents and chemotherapy, 61(8)

Nathavitharana RR, Shi CX, Chindelevitch L, Calderon R, Zhang Z, Galea JT, Contreras C, Yataco R, Lecca L, Becerra MC, Murray MB, Cohen T. (2017). Polyclonal Pulmonary Tuberculosis Infections and Risk for Multidrug Resistance, Lima, Peru. Emerging infectious diseases, 23(11)

Zelner J, Murray M, Becerra M, Galea J, Lecca L, Calderon R, Yataco R, Zhang Z, Cohen T. (2018). Protective effects of household-based TB interventions are robust to neighbourhood-level variation in exposure risk in Lima, Peru: a model-based analysis. International journal of epidemiology, 47(1)

Abel Zur Wiesch P, Clarelli F, Cohen T. (2017). Using Chemical Reaction Kinetics to Predict Optimal Antibiotic Treatment Strategies. PLoS computational biology, 13(1)

Cohen T. (2017). TM Departments Should Operate like a Business: Response to Maddock. Biomedical instrumentation & technology, 51(5)

Cohen T. (2017). HTM Departments Should Operate like a Business. Biomedical instrumentation & technology, 51(4)

Zimmer C, Yaesoubi R, Cohen T. (2017). A Likelihood Approach for Real-Time Calibration of Stochastic Compartmental Epidemic Models. PLoS computational biology, 13(1)

Colman RE, Anderson J, Lemmer D, Lehmkuhl E, Georghiou SB, Heaton H, Wiggins K, Gillece JD, Schupp JM, Catanzaro DG, Crudu V, Cohen T, Rodwell TC, Engelthaler DM. (2016). Rapid Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates Directly from Clinical Samples by Use of Amplicon Sequencing: a Proof-of-Concept Study. Journal of clinical microbiology, 54(8)

Kunkel A, Crawford FW, Shepherd J, Cohen T. (2016). Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic. AIDS (London, England), 30(17)

Houben RMGJ, Menzies NA, Sumner T, Huynh GH, Arinaminpathy N, Goldhaber-Fiebert JD, Lin HH, Wu CY, Mandal S, Pandey S, Suen SC, Bendavid E, Azman AS, Dowdy DW, Bacaër N, Rhines AS, Feldman MW, Handel A, Whalen CC, Chang ST, Wagner BG, Eckhoff PA, Trauer JM, Denholm JT, McBryde ES, Cohen T, Salomon JA, Pretorius C, Lalli M, Eaton JW, Boccia D, Hosseini M, Gomez GB, Sahu S, Daniels C, Ditiu L, Chin DP, Wang L, Chadha VK, Rade K, Dewan P, Hippner P, Charalambous S, Grant AD, Churchyard G, Pillay Y, Mametja LD, Kimerling ME, Vassall A, White RG. (2016). Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models. The Lancet. Global health, 4(11)

Menzies NA, Gomez GB, Bozzani F, Chatterjee S, Foster N, Baena IG, Laurence YV, Qiang S, Siroka A, Sweeney S, Verguet S, Arinaminpathy N, Azman AS, Bendavid E, Chang ST, Cohen T, Denholm JT, Dowdy DW, Eckhoff PA, Goldhaber-Fiebert JD, Handel A, Huynh GH, Lalli M, Lin HH, Mandal S, McBryde ES, Pandey S, Salomon JA, Suen SC, Sumner T, Trauer JM, Wagner BG, Whalen CC, Wu CY, Boccia D, Chadha VK, Charalambous S, Chin DP, Churchyard G, Daniels C, Dewan P, Ditiu L, Eaton JW, Grant AD, Hippner P, Hosseini M, Mametja D, Pretorius C, Pillay Y, Rade K, Sahu S, Wang L, Houben RMGJ, Kimerling ME, White RG, Vassall A. (2016). Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models. The Lancet. Global health, 4(11)

Heidebrecht CL, Podewils LJ, Pym AS, Cohen T, Mthiyane T, Wilson D. (2016). Assessing the utility of Xpert(®) MTB/RIF as a screening tool for patients admitted to medical wards in South Africa. Scientific reports, (6)

Cohen T, Chindelevitch L, Misra R, Kempner ME, Galea J, Moodley P, Wilson D. (2016). Within-Host Heterogeneity of Mycobacterium tuberculosis Infection Is Associated With Poor Early Treatment Response: A Prospective Cohort Study. The Journal of infectious diseases, 213(11)

Kunkel A, Abel Zur Wiesch P, Nathavitharana RR, Marx FM, Jenkins HE, Cohen T. (2016). Smear positivity in paediatric and adult tuberculosis: systematic review and meta-analysis. BMC infectious diseases, (16)

Jezmir J, Cohen T, Zignol M, Nyakan E, Hedt-Gauthier BL, Gardner A, Kamle L, Injera W, Carter EJ. (2016). Use of Lot Quality Assurance Sampling to Ascertain Levels of Drug Resistant Tuberculosis in Western Kenya. PloS one, 11(5)

Marx FM, Floyd S, Ayles H, Godfrey-Faussett P, Beyers N, Cohen T. (2016). High burden of prevalent tuberculosis among previously treated people in Southern Africa suggests potential for targeted control interventions. The European respiratory journal, 48(4)

Cohen T, Chindelevitch L, Misra R, Kempner ME, Galea J, Moodley P, Wilson D. (2016). Reply to Chen et al. The Journal of infectious diseases, 214(8)

Heidebrecht CL, Podewils LJ, Pym A, Mthiyane T, Cohen T. (2016). Assessing Local Risk of Rifampicin-Resistant Tuberculosis in KwaZulu-Natal, South Africa Using Lot Quality Assurance Sampling. PLoS One, 11(4)

Yaesoubi R, Cohen T. (2016). Identifying cost-effective dynamic policies to control epidemics. Statistics in medicine, 35(28)

Kunkel A, Cobelens FG, Cohen T. (2016). Tradeoffs in Introduction Policies for the Anti-Tuberculosis Drug Bedaquiline: A Model-Based Analysis. PLoS medicine, 13(10)

Yates TA, Khan PY, Knight GM, Taylor JG, McHugh TD, Lipman M, White RG, Cohen T, Cobelens FG, Wood R, Moore DA, Abubakar I. (2016). The transmission of Mycobacterium tuberculosis in high burden settings. The Lancet. Infectious diseases, 16(2)

Van Rie A, Cohen T. (2016). The contributions of Steve Lawn to the science, advocacy and policy of HIV-associated TB. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 20(12)

Zhang Z, Manjourides J, Cohen T, Hu Y, Jiang Q. (2016). Spatial measurement errors in the field of spatial epidemiology. International journal of health geographics, 15(1)

Lieberman TD, Wilson D, Misra R, Xiong LL, Moodley P, Cohen T, Kishony R. (2016). Genomic diversity in autopsy samples reveals within-host dissemination of HIV-associated Mycobacterium tuberculosis. Nature medicine, 22(12)

Chindelevitch L, Colijn C, Moodley P, Wilson D, Cohen T. (2016). ClassTR: Classifying Within-Host Heterogeneity Based on Tandem Repeats with Application to Mycobacterium tuberculosis Infections. PLoS computational biology, 12(2)

Theron G, Jenkins HE, Cobelens F, Abubakar I, Khan AJ, Cohen T, Dowdy DW. (2015). Data for action: collection and use of local data to end tuberculosis. Lancet, 386(10010)

Kunkel A, Colijn C, Lipsitch M, Cohen T. (2015). How could preventive therapy affect the prevalence of drug resistance? Causes and consequences. Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 370(1670)

Knight GM, Colijn C, Shrestha S, Fofana M, Cobelens F, White RG, Dowdy DW, Cohen T. (2015). The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (61Suppl 3)

Colijn C, Cohen T. (2015). How competition governs whether moderate or aggressive treatment minimizes antibiotic resistance. Elife, (4)

Salvatore PP, Becerra MC, Abel zur Wiesch P, Hinkley T, Kaur D, Sloutsky A, Cohen T. (2016). Fitness Costs of Drug Resistance Mutations in Multidrug-Resistant Mycobacterium tuberculosis: A Household-Based Case-Control Study. The Journal of infectious diseases, 213(1)

Colijn C, Cohen T. (2016). Whole-genome sequencing of Mycobacterium tuberculosis for rapid diagnostics and beyond. The Lancet. Respiratory medicine, 4(1)

Chindelevitch L, Menzies NA, Pretorius C, Stover J, Salomon JA, Cohen T. (2015). Evaluating the potential impact of enhancing HIV treatment and tuberculosis control programmes on the burden of tuberculosis. Journal of the Royal Society, Interface, 12(106)

Zelner JL, Murray MB, Becerra MC, Galea J, Lecca L, Calderon R, Yataco R, Contreras C, Zhang Z, Manjourides J, Grenfell BT, Cohen T. (2016). Identifying Hotspots of Multidrug-Resistant Tuberculosis Transmission Using Spatial and Molecular Genetic Data. The Journal of infectious diseases, 213(2)

Abel Zur Wiesch P, Abel S, Gkotzis S, Ocampo P, Engelstädter J, Hinkley T, Magnus C, Waldor MK, Udekwu K, Cohen T. (2015). Classic reaction kinetics can explain complex patterns of antibiotic action. Science translational medicine, 7(287)

Chang HH, Cohen T, Grad YH, Hanage WP, O'Brien TF, Lipsitch M. (2015). Origin and proliferation of multiple-drug resistance in bacterial pathogens. Microbiology and molecular biology reviews : MMBR, 79(1)

Plazzotta G, Cohen T, Colijn C. (2015). Magnitude and sources of bias in the detection of mixed strain M. tuberculosis infection. Journal of theoretical biology, (368)

Birger RB, Kouyos RD, Cohen T, Griffiths EC, Huijben S, Mina MJ, Volkova V, Grenfell B, Metcalf CJE. (2015). The potential impact of coinfection on antimicrobial chemotherapy and drug resistance. Trends in microbiology, 23(9)

Birger RB, Kouyos RD, Cohen T, Griffiths EC, Huijben S, Mina MJ, Volkova V, Grenfell B, Metcalf CJE. (2015). Erratum to: 'The potential impact of coinfection on antimicrobial chemotherapy and drug resistance'. Trends in microbiology, 23(11)

Jenkins HE, Tolman AW, Yuen CM, Parr JB, Keshavjee S, Pérez-Vélez CM, Pagano M, Becerra MC, Cohen T. (2014). Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet, 383(9928)

Kouyos RD, Metcalf CJ, Birger R, Klein EY, Abel zur Wiesch P, Ankomah P, Arinaminpathy N, Bogich TL, Bonhoeffer S, Brower C, Chi-Johnston G, Cohen T, Day T, Greenhouse B, Huijben S, Metlay J, Mideo N, Pollitt LC, Read AF, Smith DL, Standley C, Wale N, Grenfell B. (2014). The path of least resistance: aggressive or moderate treatment?. Proceedings. Biological sciences, 281(1794)

Jenkins HE, Crudu V, Soltan V, Ciobanu A, Domente L, Cohen T. (2014). High risk and rapid appearance of multidrug resistance during tuberculosis treatment in Moldova. The European respiratory journal, 43(4)

Jenkins HE, Pagano M, Yuen CM, Becerra MC, Cohen T. (2014). The burden of tuberculosis disease in children--Authors' reply. Lancet, 384(9951)

Zelner JL, Murray MB, Becerra MC, Galea J, Lecca L, Calderon R, Yataco R, Contreras C, Zhang Z, Grenfell BT, Cohen T. (2014). Bacillus Calmette-Guérin and isoniazid preventive therapy protect contacts of patients with tuberculosis. American journal of respiratory and critical care medicine, 189(7)

Cohen T, Jenkins HE, Lu C, McLaughlin M, Floyd K, Zignol M. (2014). On the spread and control of MDR-TB epidemics: an examination of trends in anti-tuberculosis drug resistance surveillance data. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 17(4-6)

Zelner JL, Murray MB, Becerra MC, Galea J, Lecca L, Calderon R, Yataco R, Contreras C, Zhang Z, Grenfell BT, Cohen T. (2014). Age-specific risks of tuberculosis infection from household and community exposures and opportunities for interventions in a high-burden setting. American journal of epidemiology, 180(8)

Cohen T. (2014). The Basics of CMMS. Biomedical instrumentation & technology, 48(2)

Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, Hontelez JA, Humair S, Kerr CC, Klein DJ, Mishra S, Mitchell KM, Nichols BE, Vickerman P, Bakker R, Bärnighausen T, Bershteyn A, Bloom DE, Boily MC, Chang ST, Cohen T, Dodd PJ, Fraser C, Gopalappa C, Lundgren J, Martin NK, Mikkelsen E, Mountain E, Pham QD, Pickles M, Phillips A, Platt L, Pretorius C, Prudden HJ, Salomon JA, van de Vijver DA, de Vlas SJ, Wagner BG, White RG, Wilson DP, Zhang L, Blandford J, Meyer-Rath G, Remme M, Revill P, Sangrujee N, Terris-Prestholt F, Doherty M, Shaffer N, Easterbrook PJ, Hirnschall G, Hallett TB. (2014). Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. The Lancet. Global health, 2(1)

Yuen CM, Tolman AW, Cohen T, Parr JB, Keshavjee S, Becerra MC. (2013). Isoniazid-resistant tuberculosis in children: a systematic review. The Pediatric infectious disease journal, 32(5)

Yaesoubi R, Cohen T. (2013). Identifying dynamic tuberculosis case-finding policies for HIV/TB coepidemics. Proceedings of the National Academy of Sciences of the United States of America, 110(23)

Izu A, Cohen T, Degruttola V. (2013). Bayesian estimation of mixture models with prespecified elements to compare drug resistance in treatment-naïve and experienced tuberculosis cases. PLoS computational biology, 9(3)

Robinson K, Fyson N, Cohen T, Fraser C, Colijn C. (2013). How the dynamics and structure of sexual contact networks shape pathogen phylogenies. PLoS computational biology, 9(6)

Mitnick CD, Keravec J, Cohen T. (2013). Planning for the invisible: projecting resources needed to identify and treat all patients with MDR-TB. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 17(4)

Ford CB, Shah RR, Maeda MK, Gagneux S, Murray MB, Cohen T, Johnston JC, Gardy J, Lipsitch M, Fortune SM. (2013). Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis. Nature genetics, 45(7)

Mills HL, Cohen T, Colijn C. (2013). Community-wide isoniazid preventive therapy drives drug-resistant tuberculosis: a model-based analysis. Science translational medicine, 5(180)

Jenkins HE, Plesca V, Ciobanu A, Crudu V, Galusca I, Soltan V, Serbulenco A, Zignol M, Dadu A, Dara M, Cohen T. (2013). Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country. The European respiratory journal, 42(5)

Sergeev R, Colijn C, Murray M, Cohen T. (2012). Modeling the dynamic relationship between HIV and the risk of drug-resistant tuberculosis. Science translational medicine, 4(135)

Lin HH, Shin SS, Contreras C, Asencios L, Paciorek CJ, Cohen T. (2012). Use of spatial information to predict multidrug resistance in tuberculosis patients, Peru. Emerging infectious diseases, 18(5)

Robinson K, Cohen T, Colijn C. (2012). The dynamics of sexual contact networks: effects on disease spread and control. Theoretical population biology, 81(2)

Hedt BL, van Leth F, Zignol M, Cobelens F, van Gemert W, Nhung NV, Lyepshina S, Egwaga S, Cohen T. (2012). Multidrug resistance among new tuberculosis cases: detecting local variation through lot quality-assurance sampling. Epidemiology (Cambridge, Mass.), 23(2)

Cohen T, Manjourides J, Hedt-Gauthier B. (2012). Linking surveillance with action against drug-resistant tuberculosis. American journal of respiratory and critical care medicine, 186(5)

Manjourides J, Lin HH, Shin S, Jeffery C, Contreras C, Cruz JS, Jave O, Yagui M, Asencios L, Pagano M, Cohen T. (2012). Identifying multidrug resistant tuberculosis transmission hotspots using routinely collected data. Tuberculosis (Edinburgh, Scotland), 92(3)

Lin HH, Dowdy D, Dye C, Murray M, Cohen T. (2012). The impact of new tuberculosis diagnostics on transmission: why context matters. Bulletin of the World Health Organization, 90(10)

Cohen T, van Helden PD, Wilson D, Colijn C, McLaughlin MM, Abubakar I, Warren RM. (2012). Mixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control. Clinical microbiology reviews, 25(4)

Colijn C, Cohen T, Ganesh A, Murray M. (2011). Spontaneous emergence of multiple drug resistance in tuberculosis before and during therapy. PloS one, 6(3)

Jenkins HE, Zignol M, Cohen T. (2011). Quantifying the burden and trends of isoniazid resistant tuberculosis, 1994-2009. PLoS One, 6(7)

Sergeev R, Colijn C, Cohen T. (2011). Models to understand the population-level impact of mixed strain M. tuberculosis infections. Journal of theoretical biology, 280(1)

Cohen T, Corbett EL. (2011). Test and treat in HIV: success could depend on rapid detection. Lancet, 378(9787)

Yaesoubi R, Cohen T. (2011). Dynamic health policies for controlling the spread of emerging infections: influenza as an example. PLoS One, 6(9)

Yaesoubi R, Cohen T. (2011). Generalized Markov Models of Infectious Disease Spread: A Novel Framework for Developing Dynamic Health Policies. European journal of operational research, 215(3)

Cohen T. (2011). Staffing metrics: a case study. Biomedical instrumentation & technology, 45(4)

Cohen T, Murray M, Abubakar I, Zhang Z, Sloutsky A, Arteaga F, Chalco K, Franke MF, Becerra MC. (2011). Multiple introductions of multidrug-resistant tuberculosis into households, Lima, Peru. Emerging infectious diseases, 17(6)

Hedt BL, Laufer MK, Cohen T. (2011). Drug resistance surveillance in resource-poor settings: current methods and considerations for TB, HIV, and malaria. The American journal of tropical medicine and hygiene, 84(2)

Cohen T, Wilson D, Wallengren K, Samuel EY, Murray M. (2011). Mixed-strain Mycobacterium tuberculosis infections among patients dying in a hospital in KwaZulu-Natal, South Africa. Journal of clinical microbiology, 49(1)

Lipsitch M, Tchetgen Tchetgen E, Cohen T. (2010). Negative controls: a tool for detecting confounding and bias in observational studies. Epidemiology (Cambridge, Mass.), 21(3)

Shin SS, Keshavjee S, Gelmanova IY, Atwood S, Franke MF, Mishustin SP, Strelis AK, Andreev YG, Pasechnikov AD, Barnashov A, Tonkel TP, Cohen T. (2010). Development of extensively drug-resistant tuberculosis during multidrug-resistant tuberculosis treatment. American journal of respiratory and critical care medicine, 182(3)

Cohen T, Murray M, Wallengren K, Alvarez GG, Samuel EY, Wilson D. (2010). The prevalence and drug sensitivity of tuberculosis among patients dying in hospital in KwaZulu-Natal, South Africa: a postmortem study. PLoS medicine, 7(6)

Cohen T, Hedt BL, Pagano M. (2010). Estimating the magnitude and direction of bias in tuberculosis drug resistance surveys conducted only in the public sector: a simulation study. BMC Public Health, (10)

Brooks-Pollock E, Cohen T, Murray M. (2010). The impact of realistic age structure in simple models of tuberculosis transmission. PloS one, 5(1)

Cohen T. (2010). AAMI's benchmarking solution: analysis of cost of service ratio and other metrics. Biomedical instrumentation & technology, 44(4)

Colijn C, Cohen T, Fraser C, Hanage W, Goldstein E, Givon-Lavi N, Dagan R, Lipsitch M. (2010). What is the mechanism for persistent coexistence of drug-susceptible and drug-resistant strains of Streptococcus pneumoniae?. Journal of the Royal Society, Interface, 7(47)

Lipsitch M, Lajous M, O'Hagan JJ, Cohen T, Miller JC, Goldstein E, Danon L, Wallinga J, Riley S, Dowell SF, Reed C, McCarron M. (2009). Use of cumulative incidence of novel influenza A/H1N1 in foreign travelers to estimate lower bounds on cumulative incidence in Mexico. PLoS One, 4(9)

Lipsitch M, Colijn C, Cohen T, Hanage WP, Fraser C. (2009). No coexistence for free: neutral null models for multistrain pathogens. Epidemics, 1(1)

Cohen T, Dye C, Colijn C, Williams B, Murray M. (2009). Mathematical models of the epidemiology and control of drug-resistant TB. Expert review of respiratory medicine, 3(1)

Cohen T, Colijn C, Wright A, Zignol M, Pym A, Murray M. (2008). Challenges in estimating the total burden of drug-resistant tuberculosis. American journal of respiratory and critical care medicine, 177(12)

Blaya JA, Cohen T, Rodríguez P, Kim J, Fraser HS. (2009). Personal digital assistants to collect tuberculosis bacteriology data in Peru reduce delays, errors, and workload, and are acceptable to users: cluster randomized controlled trial. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 13(3)

Cohen T, Lipsitch M. (2008). Too little of a good thing: a paradox of moderate infection control. Epidemiology (Cambridge, Mass.), 19(4)

Colijn C, Cohen T, Murray M. (2009). Latent coinfection and the maintenance of strain diversity. Bulletin of mathematical biology, 71(1)

Dagan R, Barkai G, Givon-Lavi N, Sharf AZ, Vardy D, Cohen T, Lipsitch M, Greenberg D. (2008). Seasonality of antibiotic-resistant streptococcus pneumoniae that causes acute otitis media: a clue for an antibiotic-restriction policy?. The Journal of infectious diseases, 197(8)

Cohen T, Colijn C, Murray M. (2008). Modeling the effects of strain diversity and mechanisms of strain competition on the potential performance of new tuberculosis vaccines. Proceedings of the National Academy of Sciences of the United States of America, 105(42)

Lin HH, Murray M, Cohen T, Colijn C, Ezzati M. (2008). Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study. Lancet, 372(9648)

Cohen T, Colijn C, Finklea B, Wright A, Zignol M, Pym A, Murray M. (2008). Are survey-based estimates of the burden of drug resistant TB too low? Insight from a simulation study. PLoS One, 3(6)

Cohen T, Colijn C, Finklea B, Murray M. (2007). Exogenous re-infection and the dynamics of tuberculosis epidemics: local effects in a network model of transmission. Journal of the Royal Society, Interface, 4(14)

Colijn C, Cohen T, Murray M. (2007). Emergent heterogeneity in declining tuberculosis epidemics. Journal of theoretical biology, 247(4)

Lipsitch M, Cohen T, Murray M, Levin BR. (2007). Antiviral resistance and the control of pandemic influenza. PLoS medicine, 4(1)

Cohen T, Lipsitch M, Walensky RP, Murray M. (2006). Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations. Proceedings of the National Academy of Sciences of the United States of America, 103(18)

Cohen T, Ellis WS, Morrissey JJ, Bakuzonis C, David Y, Paperman WD. (2005). Safe use of cellular telephones in hospitals: fundamental principles and case studies. Journal of healthcare information management : JHIM, 19(4)

Bageris A, Cohen T. (2005). Maternal hypertension and neonatal outcome among small for gestational age infants. Obstetrics and gynecology, 106(6)

Cohen T, Murray M. (2005). Incident tuberculosis among recent US immigrants and exogenous reinfection. Emerging infectious diseases, 11(5)

Cohen T, Murray M. (2004). Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness. Nature medicine, 10(10)

Cohen T. (2004). Medical and information technologies converge. IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society, 23(3)

Cohen T, Becerra MC, Murray MB. (2004). Isoniazid resistance and the future of drug-resistant tuberculosis. Microbial drug resistance (Larchmont, N.Y.), 10(4)

Lipsitch M, Cohen T, Cooper B, Robins JM, Ma S, James L, Gopalakrishna G, Chew SK, Tan CC, Samore MH, Fisman D, Murray M. (2003). Transmission dynamics and control of severe acute respiratory syndrome. Science (New York, N.Y.), 300(5627)

Cohen T. (2003). The future of clinical engineering: technology that enables improved patient care. Biomedical instrumentation & technology, 37(2)

Cohen T. (2003). Striving for "end-to-end" knowledge to support networked medical systems. Biomedical instrumentation & technology, (Suppl)

Cohen T, Sommers B, Murray M. (2003). The effect of drug resistance on the fitness of Mycobacterium tuberculosis. The Lancet. Infectious diseases, 3(1)

Cohen T. (2002). Leadership challenges in clinical and information technology services. Biomedical instrumentation & technology, 36(2)

If you’d like to update your profile, please email modifications to